INTENTION TO TREAT - WHO SHOULD USE ITT

被引：157

作者：

LEWIS, JA ^{[1
]}

MACHIN, D ^{[1
]}

机构：

[1] MRC, CANC TRIALS OFF, CAMBRIDGE CB2 2BB, ENGLAND

来源：

关键词：

D O I：

10.1038/bjc.1993.402

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：647 / 650

页数：4

共 26 条

[1] [Anonymous], 1990, Lancet, V336, P1
[2] EPANOLOL AS A MODEL FOR ASSESSING PATIENT PREFERENCE IN ANTIANGINAL DRUG-THERAPY
BLAKE, P
LEWIS, JA
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (01) : 85 - 90
[3] A MEDICAL-RESEARCH COUNCIL (MRC) RANDOMIZED TRIAL OF PALLIATIVE RADIOTHERAPY WITH 2 FRACTIONS OR A SINGLE FRACTION IN PATIENTS WITH INOPERABLE NON-SMALL-CELL LUNG-CANCER (NSCLC) AND POOR PERFORMANCE STATUS
BLEEHEN, NM
BOLGER, JJ
GIRLING, DJ
HASLETON, PS
HOPWOOD, P
MACBETH, FR
MACHIN, D
MOGHISSI, K
SAUNDERS, M
STEPHENS, RJ
THATCHER, N
WHITE, RJ
[J]. BRITISH JOURNAL OF CANCER, 1992, 65 (06) : 934 - 941
[4] Fisher L., 1990, STAT ISSUES DRUG RES, P331, DOI DOI 10.1201/9780203738610
[5] THE ANALYSIS OF FAILURE TIME DATA IN CROSSOVER STUDIES
FRANCE, LA
LEWIS, JA
KAY, R
[J]. STATISTICS IN MEDICINE, 1991, 10 (07) : 1099 - 1113
[6] FRIEDMAN LM, 1982, FUNDAMENTALS CLIN TR, P244
[7] GAIL MH, 1985, CANCER TREAT REP, V69, P1107
[8] GILLINGS D, 1991, DRUG INF J, V25, P411, DOI DOI 10.1177/009286159102500311
[9] A NEW APPROACH TO THE ANALYSIS OF CLINICAL DRUG TRIALS WITH WITHDRAWALS
GOULD, AL
[J]. BIOMETRICS, 1980, 36 (04) : 721 - 727
[10] HILL AB, 1971, LANCET, P264